Sunday, April 15: 1-4pm
12:00-1:00pm Short Course Registration
Microfluidics Technology and Market Trends*
In recent years, microfluidic and micro/nano technologies have transformed research and experienced impressive market growth allowing novel applications and market avenues. The impact of these enabling technologies will make it essential to adapt current strategies to meet future demands. This course will bring attendees up to date on technological advances, commercial applications of microfluidic technology, and market trends. Macroeconomic and regulatory aspects in the commercialization of new diagnostics products based on those micro technologies are becoming more and more urgent topics in the invention and development of new products. An overview of the microfluidic market for in vitro diagnostics will be presented as well as keys to market entry and future perspectives.
1:00 Opening Remarks
1:05 Overview of Microfluidic Technology Advances
Richard Selden, M.D., Ph.D., CEO, NetBio
1:50 Break
2:10 Commercialization of IVD Technologies
Ali Tinazli, Ph.D., Director, Business Development & Sales, BioSciences - North America, Sony DADC Austria AG
2:55 Survey of Technology Trends and Perspective on Hurdles to Market Entry
Leanna Levine, Ph.D., President and CEO, ALine, Inc.
3:40 Panel: Future Perspectives (with speakers)
4:00 Close of Course
*Separate Registration Required
*This course is not CME accredited
Tuesday, April 17 | 6:30 – 8:30 pm
Guidelines for Commercial Launch of Novel Diagnostics
This short course is focused on development of molecular diagnostics as they make their way from identification of a medical need through to commercial launch. The course will emphasize identification of critical hurdles that when addressed early, can materially accelerate progress. Vital areas to be addressed include disease management, validation, reimbursement strategies including provider engagement, regulatory pathway decisions and education of the medical community. Examples and case studies of diagnostic companies will be shared to illustrate a real world roadmap including:
- Disease Management
- Assay Validation
- Regulatory Pathways and Considerations
- Reimbursement
- Acceptance and Adoption
Instructors:
Bill Cook, Principal, WECA
Dwight Denham, MBA, Director, Clinical Research, Health Economics &. Reimbursement Affairs (CHRA), Beckman Coulter, Inc.
*Separate Registration Required